Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $151.00 -0.15%
EPS Growth %: -14.2%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -14.2%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.07 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Asana, Inc. (ASAN) Tops Q2 EPS by 1c; offers guidance
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
